High-pressure injection injuries occur when a high-pressure injection device such as a paint or grease gun injects material into the operator. This injury most commonly occurs in the dominant hand and index finger.[1] However, cases involving the arms, feet, abdomen, and even cervical spine have been reported.[2, 3] Most injuries result from grease guns, paint sprayers, or diesel fuel injectors.[4] Often, the injury may initially appear insignificant or benign. Future disability may be hidden behind a small, punctuate sore on the finger.[5, 6] The clinical effects of the high-pressure injection injury depend upon a number of variables, including the pressures involved, chemical toxicity, and the quantity of material injected and its temperature.[7, 8, 9, 10, 11]
The injection typically occurs to the fingertip when the operator is trying to wipe clear a blocked nozzle or to the palm when the operator is attempting to steady the gun with a free hand during the testing or operation of equipment. The left hand (usually nondominant) is involved in about two thirds of cases. The most common site of injury is the index finger. The palm and long finger are the next most frequently injured.[12, 13]
The innocuous appearance of the wound may hide the severity of the injury.[14, 15, 16] With time, edema and intense pain develop and the digit may appear erythematous or cold.
Emergency department care for high-pressure injection hand injuries includes the following:
A high-pressure injection injury should be considered a surgical emergency. Immediate decompression and thorough cleansing of the offending material from the tissue is required to preserve optimal function. Emergent consultation with an experienced hand surgeon is required. Prompt surgical debridement optimizes tissue salvage. Diagnosis is clinical and based largely on patient history. However, secondary to the surgical nature of these injuries, routine preoperative evaluation may be initiated in the emergency department. Laboratory tests may include complete blood cell (CBC) count, electrolyte values and renal function, cardiography, and chest radiography. Radiographs may facilitate the surgical strategy by localizing subcutaneous air, debris, or unanticipated fractures.[17]
Initial treatment of high-pressure injection injury includes tetanus prophylaxis, broad-spectrum antibiotics, and consultation with a hand surgeon. Injections with air, gas, or small amounts of veterinary vaccines can usually be managed with observation and serial examinations if there is no concern about compartment syndrome. Injections with other liquid materials may require emergent surgical débridement, with the best results when the injury is treated within 6 hours. Wide surgical irrigation and debridement of necrotic tissues should be performed under general or regional anesthesia. Organic and caustic materials are associated with a higher amputation rate, and decreasing the time from injury to surgery improves the prognosis.[18]
Extravasation of the injected material may further jeopardize the limb. Prompt decompression and directed debridement of the nonviable tissue is an important strategy to prevent further tissue damage. Less-aggressive therapy may have a role in injection injuries with less irritating substances (eg, Freon).[19, 20] HPI injuries involving grease and paint are considered surgical emergencies, whereas HPI injuries with other substances require careful clinical evaluation, surgical intervention, or both. Clean water and air injuries may result in good functional outcomes with simple monitoring and conservative management.[21, 22]
A retrospective review of 19 high-pressure water-injection injuries of the hand reported that16% of patients developed infection and that 33% of patients without early debridement eventually required surgery, including debridement of a septic flexor tenosynovitis, fingertip amputation, and metacarpophalangeal disarticulation. The authors noted that high-pressure water-injection injuries warrant immediate medical attention, early antibiotics, and a low threshold for close observation or surgical debridement.[17]
(See the images below.)
View Image | Photograph taken approximately 12 hours after high-pressure injection injury involving paint. |
View Image | Photograph taken after urgent debridement following high-pressure injection injury involving paint. |
View Image | Photograph taken after urgent debridement following high-pressure injection injury involving paint. |
View Image | Debridement of necrotic index and middle digits following treatment of high-pressure injection injury involving paint. |
Overall incidence of amputation approaches 48%.[23] Morbidity is dependent to a large degree upon the material injected. Paint solvents appear to cause the greatest damage and result in amputation in 60-80% of the cases. Grease, the more common injectant, causes a less severe inflammatory response. Amputation is necessary in about 25% of these patients.[24]
These injuries are rare in women. High-pressure hand injuries usually occur in young men while working, most often to their nondominant index finger. The average age at time of injury in one large review was 35 years (range, 16-65 y). These injuries occurred to the nondominant hand 76% of the time.[24]
Factors that determine the severity of the injury include the following:
Injection of irritating substances under high pressure has the potential for disability and amputation despite prompt aggressive therapy.
A case series of 8 patients with high-pressure injection injury to their hand who underwent surgical debridement, reported long-term outcomes that included the following[25] :
In cases of high-pressure injection (HPI) injury, a complete history should be obtained that includes mechanism of injury, materials injected, timeline, and pressure of machine at the time of injury.
The physical examination should include circulation in the digit and evaluation for compartment syndrome.
Radiographs may be helpful to help facilitate the surgical strategy by localizing subcutaneous air, debris, or unanticipated fractures.[17]
The entrance site of an HPI injury is often deceptively small, and the injected material acts as a projectile. The physician must look for possible exit sites as well. Some clinicians may send the patient home with analgesia and reassurance because the injury seems benign, only to have the patient return to the hospital with excruciating pain and and an inability to move the involved finger or hand.[15, 16]
Depending on the volume and type of materials injected, the finger may be distended, swollen, and tender on palpation. If vessels ihave been thrombosed or compressed, the digit may be pale, anesthetic, or even ischemic. Associated crepitus and subcutaneous emphysema are possible in cases of an air-injection injuries.
The goal of therapy is to prevent infections. Prophylactic broad-spectrum antibiotics are indicated.
Clinical Context: DOC; first-generation semisynthetic cephalosporin which, by binding to one or more penicillin-binding proteins, arrests bacterial cell wall synthesis and inhibits bacterial growth. Primarily active against skin flora, including Staphylococcus aureus.
Clinical Context: Inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid, inhibiting folic acid synthesis and thus bacterial growth. Antibacterial activity of TMP-SMZ includes common urinary tract pathogens except Pseudomonas aeruginosa.
Clinical Context: Lincosamide useful as treatment against serious skin and soft-tissue infections caused by most staphylococci strains. Also effective against aerobic and anaerobic streptococci, except enterococci.
Clinical Context: Treats susceptible bacterial infections of both gram-positive and gram-negative organisms, as well as infections caused by Mycoplasma, Chlamydia, and Rickettsia species. Inhibits bacterial protein synthesis by binding with 30S and possibly 50S ribosomal subunit(s) of susceptible bacteria.
Clinical Context: Interferes with synthesis of cell wall mucopeptide during active multiplication, resulting in bactericidal activity against susceptible bacteria.
Therapy must cover all likely pathogens in the context of the clinical setting.